Acute graft-versus-host disease (GVHD) usually occurs 10-21 days after bone marrow transplantation. The clinical staging and grading of acute graft versus host disease (GVHD) can be made by evaluating the skin, liver, gastrointestinal tract and performance level of the patient.
Stages of GVHD by Organ System
Skin Findings |
Stage |
---|---|
maculopapular rash < 25% of body surface |
1 |
maculopapular rash 25-50% of body surface |
2 |
generalized erythroderma |
3 |
generalized erythroderma with bulla and desquamation |
4 |
Liver Findings |
Stage |
---|---|
bilirubin 2-3 mg/dL |
1 |
bilirubin 3-6 mg/dL |
2 |
bilirubin 6-15 mg/dL |
3 |
bilirubin > 15 mg/dL |
4 |
Intestinal Tract Findings |
Stage |
---|---|
> 500 mL diarrhea per day |
1 |
> 1000 mL diarrhea per day |
2 |
> 1500 mL diarrhea per day |
3 |
severe abdominal pain with/without ileus |
4 |
Grade of Acute GVHD
Degree of Organ Involvement |
Grade |
---|---|
• skin: rash stage 1-2 • intestinal tract involvement: none • liver involvement: none • clinical performance: no decrease |
1 |
• skin: rash stage 1-3 • intestinal tract involvement: stage 1 AND/OR liver involvement: stage 1 • clinical performance: mild decrease |
2 |
• skin: rash stage 2-3 • intestinal tract involvement: stage 2-3 AND/OR liver involvement: stage 2-3 • clinical performance: marked decrease |
3 |
• skin: rash stage 2-4 • intestinal tract involvement: stage 2-4 AND/OR liver involvement: stage 2-4 • clinical performance: extreme decrease |
4 |
Purpose: To stage acute graft-versus-host disease (GVHD) based on the clinical examination of the patient.
Specialty: Immunology/Rheumatology
Objective: severity, prognosis, stage
ICD-10: T86.0,